Consumer wearable heart-rate sensors are reasonably accurate for resting heart rate but show variable accuracy during movement, high-intensity exercise, and clinical measurements. The most common method in wrist devices is photoplethysmography, which measures blood volume changes under the skin and is mediated by optical sensors and proprietary algorithms. Independent research and regulatory bodies agree that optical heart-rate signals are useful for everyday tracking but have important limitations when used for medical decisions.
Evidence from studies and institutions
A large population study known as the Apple Heart Study was led by Marco V. Perez at Stanford University and collaborators and demonstrated that smartwatch pulse detection can identify irregular rhythms at scale while also producing many signals that require clinical follow-up. Researchers at Scripps Research Translational Institute led by Jennifer Radin examined wearable pulse and heart-rate data and showed that aggregated wearable signals can track population-level changes such as illness outbreaks. The Food and Drug Administration has provided guidance noting that consumer optical sensors are not equivalent to clinical electrocardiograms and that some smartwatch features intended to detect arrhythmia have received FDA clearance only after clinical validation. These institutional findings establish that consumer wearables can be scientifically useful while also requiring careful interpretation.
Key causes of measurement error
Limitations arise from both hardware and context. The optical photoplethysmography method is sensitive to motion artifacts, so readings during running or vigorous arm movement are commonly distorted. Skin characteristics including pigmentation and tattoos can reduce signal quality, and environmental lighting and poor fit on the wrist also degrade accuracy. Device algorithms differ greatly between manufacturers and are frequently updated, so two watches worn simultaneously can report different values even under the same conditions. Devices that provide ECG tracings use different sensors and are generally more reliable for rhythm diagnosis than optical heart-rate estimates.
Consequences for users and clinicians
For everyday use, such as monitoring resting heart rate trends and activity-related changes, consumer wearables offer actionable value and encourage healthier behaviors. However, relying on wrist photoplethysmography for acute clinical decisions can lead to false reassurance or unnecessary alarm. When arrhythmia detection is suspected, clinicians rely on medical-grade ECG recordings rather than optical wrist sensors. Regulatory clearance of specific features, such as the single-lead ECG on some smartwatches, means those features met clinical validation standards but does not make every heart-rate figure on a device diagnostic.
Human and cultural factors matter. Access to validated devices, trust in technology, and skin diversity influence who benefits and who may receive misleading signals. In many regions, wearables remain consumer luxury items and their population impact depends on local healthcare integration. Understanding both the strengths and the limitations of wearable heart-rate measurements allows users to use them confidently for lifestyle monitoring while seeking professional assessment for clinical concerns.